Arbutus Biopharma Corporation (LON:0SGC)

Arbutus Biopharma Ratios and Metrics

Market cap in millions GBP. Fiscal year is January - December.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jan 30, 2025	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	513	329	303	389	221	130
Market Cap Growth	94.55%	8.78%	-22.14%	76.02%	69.34%	-21.80%
Enterprise Value	415	223	157	411	258	181
Last Close Price	2.67	1.96	1.92	2.95	-	-
PS Ratio	107.80	23.11	9.34	47.89	43.60	28.73
PB Ratio	6.80	3.95	2.66	3.11	2.96	2.37
P/TBV Ratio	6.80	3.95	2.66	3.11	-	-
EV/Sales Ratio	77.73	15.69	4.84	50.59	51.00	39.78
Debt / Equity Ratio	0.06	0.08	0.09	0.11	0.22	0.31
Asset Turnover	0.05	0.11	0.20	0.06	0.06	0.04
Quick Ratio	6.85	5.68	4.51	13.92	13.06	11.76
Current Ratio	7.02	5.87	4.60	14.32	13.38	11.99
Return on Equity (ROE)	-67.81%	-59.99%	-45.35%	-56.19%	-72.97%	-112.63%
Return on Assets (ROA)	-32.83%	-28.70%	-19.76%	-26.22%	-29.51%	-25.47%
Return on Capital (ROIC)	-40.40%	-36.93%	-23.40%	-28.63%	-32.60%	-28.76%
Earnings Yield	-11.16%	-17.38%	-19.05%	-14.49%	-21.15%	-89.03%
FCF Yield	-10.47%	-20.74%	-9.84%	-12.99%	-17.14%	-41.46%
Buyback Yield / Dilution	-10.83%	-9.95%	-42.07%	-40.10%	-32.83%	-3.24%
Total Shareholder Return	-10.83%	-9.95%	-42.07%	-40.10%	-32.83%	-3.24%

Source: S&P Capital IQ. Standard template. Financial Sources.